2,3-Dehydroderivatives of Silymarin Flavonolignans: Prospective Natural Compounds for the Prevention of Chronic Diseases †
Abstract
:1. Introduction
2. Materials and Methods
3. Results
4. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Chambers, C.S.; Holečková, V.; Petrásková, L.; Biedermann, D.; Valentová, K.; Buchta, M.; Křen, V. The silymarin composition and why does it matter? Food Res. Int. 2017, 100, 339–353. [Google Scholar] [CrossRef] [PubMed]
- Křenek, K.; Marhol, P.; Peikerová, Ž.; Křen, V.; Biedermann, D. Preparatory separation of the silymarin flavonolignans by Sephadex LH-20 gel. Food Res. Int. 2014, 65, 115–120. [Google Scholar] [CrossRef]
- Biedermann, D.; Vavříková, E.; Cvak, L.; Křen, V. Chemistry of silybin. Nat. Prod. Rep. 2014, 31, 1138–1157. [Google Scholar] [CrossRef] [PubMed]
- Pyszková, M.; Biler, M.; Biedermann, D.; Valentová, K.; Kuzma, M.; Vrba, J.; Ulrichová, J.; Sokolová, R.; Mojovic, M.; Popovic-Bijelic, A.; et al. Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity. Free Radical Bio. Med. 2016, 90, 114–125. [Google Scholar] [CrossRef] [PubMed]
- Monti, D.; Gažák, R.; Marhol, P.; Biedermann, D.; Purchartová, K.; Fedrigo, M.; Riva, S.; Křen, V. Enzymatic kinetic resolution of silybin diastereoisomers. J. Nat. Prod. 2010, 73, 613–619. [Google Scholar] [CrossRef] [PubMed]
- Gažák, R.; Marhol, P.; Purchartová, K.; Monti, D.; Biedermann, D.; Riva, S.; Cvak, L.; Křen, V. Large-scale separation of silybin diastereoisomers using lipases. Process Biochem. 2010, 45, 1657–1663. [Google Scholar] [CrossRef]
- Biedermann, D.; Buchta, M.; Holečková, V.; Sedlák, D.; Valentová, K.; Cvačka, J.; Bednárová, L.; Křenková, A.; Kuzma, M.; Škuta, C.; et al. Silychristin: Skeletal alterations and biological activities. J. Nat. Prod. 2016, 79, 3086–3092. [Google Scholar] [CrossRef] [PubMed]
- Biedermann, D.; Moravcová, V.; Valentová, K.; Kuzma, M.; Petrásková, L.; Císařová, I.; Křen, V. Oxidation of flavonolignan silydianin to unexpected lactone-acid derivative. Phytochem. Lett. 2019, 30, 14–20. [Google Scholar] [CrossRef]
- Valentová, K.; Purchartová, K.; Rydlová, L.; Roubalová, L.; Biedermann, D.; Petrásková, L.; Křenková, A.; Pelantová, H.; Holečková-Moravcová, V.; Tesařová, E.; et al. Sulfated metabolites of flavonolignans and 2,3-dehydroflavonolignans: Preparation and properties. Int. J. Mol. Sci. 2018, 19, 2349. [Google Scholar] [CrossRef] [PubMed]
- Tvrdý, V.; Catapano, M.C.; Rawlik, T.; Karlíčková, J.; Biedermann, D.; Křen, V.; Mladěnka, P.; Valentová, K. Interaction of isolated silymarin flavonolignans with iron and copper. J. Inorg. Biochem. 2018, 189, 115–123. [Google Scholar] [CrossRef] [PubMed]
- Roubalová, L.; Dinkova-Kostova, A.T.; Biedermann, D.; Křen, V.; Ulrichová, J.; Vrba, J. Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H: Quinone oxidoreductase 1 in Hepa1c1c7 cells. Fitoterapia 2017, 119, 115–120. [Google Scholar] [CrossRef] [PubMed]
- Gažák, R.; Valentová, K.; Fuksová, K.; Marhol, P.; Kuzma, M.; Medina, M.A.; Oborná, I.; Ulrichová, J.; Křen, V. Synthesis and antiangiogenic activity of new silybin galloyl esters. J. Med. Chem. 2011, 54, 7397–7407. [Google Scholar] [CrossRef] [PubMed]
- Karas, D.; Gažák, R.; Valentová, K.; Chambers, C.S.; Pivodová, V.; Biedermann, D.; Křenková, A.; Oborná, I.; Kuzma, M.; Cvačka, J.; et al. Effects of 2,3-Dehydrosilybin and its galloyl ester and methyl ether derivatives on human umbilical vein endothelial cells. J. Nat. Prod. 2016, 79, 812–820. [Google Scholar] [CrossRef] [PubMed]
- Filippopoulou, K.; Papaevgeniou, N.; Lefaki, M.; Paraskevopoulou, A.; Biedermann, D.; Křen, V.; Chondrogianni, N. 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radical Bio. Med. 2017, 103, 256–267. [Google Scholar] [CrossRef] [PubMed]
- Tilley, C.; Deep, G.; Agarwal, C.; Wempe, M.F.; Biedermann, D.; Valentova, K.; Kren, V.; Agarwal, R. Silibinin and its 2,3-Dehydro-Derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Mol. Carcinog. 2016, 55, 3–14. [Google Scholar] [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Valentová, K.; Biedermann, D.; Křen, V. 2,3-Dehydroderivatives of Silymarin Flavonolignans: Prospective Natural Compounds for the Prevention of Chronic Diseases. Proceedings 2019, 11, 21. https://doi.org/10.3390/proceedings2019011021
Valentová K, Biedermann D, Křen V. 2,3-Dehydroderivatives of Silymarin Flavonolignans: Prospective Natural Compounds for the Prevention of Chronic Diseases. Proceedings. 2019; 11(1):21. https://doi.org/10.3390/proceedings2019011021
Chicago/Turabian StyleValentová, Kateřina, David Biedermann, and Vladimír Křen. 2019. "2,3-Dehydroderivatives of Silymarin Flavonolignans: Prospective Natural Compounds for the Prevention of Chronic Diseases" Proceedings 11, no. 1: 21. https://doi.org/10.3390/proceedings2019011021